- Mechanisms of Hypertension
- RAA System Drugs
- Adrenoceptor Drugs
- Ion Channel Drugs
- Other Drugs

---
#### **Mechanisms of Hypertension**
- Cardiovascular Dysfunction
	- ↑ <abbr Title="Cardiac Output">CO</abbr>: ↑ <abbr Title="Stroke Volume">SV</abbr> / <abbr Title="Heart Rate">HR</abbr>
	- ↑ Peripheral Vascular Resistance: Impaired Vasodilation / Atherosclerosis
- Hormonal Dysregulation
	- RAA System
		- Angiotensin II: Vasoconstriction, ↑ Aldosterone Secretion & Sympathetic Tone
		- Aldosterone: ↑ Na<sup>+</sup> & Water Reabsorption → Fluid Retention
- Neural Dysregulation
	- ↑ Sympathetic Tone from Stress / Angiotensin II
- Other Factors
	- Lifestyle: Diet & Obesity
	- Genetic: Family History


#### **RAA System Drugs**
- Aim: ↓ Lowers Angiotensin II Activity
	- ACE Inhibitors
	- Angiotensin II Type 1 Receptor Antagonists

**Angiotensin Converting Enzyme (ACE) Inhibitors**
- Suffix: -pril (e.g. Benazepril, Captopril, Cilazapril)
- Mechanism:

| Step  | Event            | Effect                                               |
| ----- | ---------------- | ---------------------------------------------------- |
| 1     | ACE Inhibition   | ↓ Angiotensin I to II Conversion                     |
| <br>2 | ↓ Angiotensin II | Vasodilation<br>↓ Aldosterone & Sympathetic Activity |
| ^     | ↑ Bradykinin     | Vasodilation                                         |
| 3     | ↓ Aldosterone    | ↓ Na<sup>+</sup> & Water Reabsorption                |
- Site of Action & Elimination
	- Action: Heart, Blood Vessels, Brain, Adrenal Glands & Kidney
	- Elimination: Liver & Kidney

**Angiotensin II Receptor Antagonists**
- Suffix: -sartan (e.g. Losartan, Telmisartan, Valsartan)
- Mechanism:

| Step | Event           | Description                                                                    |
| ---- | --------------- | ------------------------------------------------------------------------------ |
| 1    | AT1R Inhibition | Selective Blockage of <abbr Title="Angiotensin II Type 1 Receptor">AT1R</abbr> |
| 2    | ↓ AT1R Effect   | Vasodilation <br>↓ Aldosterone & Sympathetic Activity                          |
| 3    | ↓ Aldosterone   | ↓ Na<sup>+</sup> & Water Reabsorption                                          |
- Site of Action & Elimination
	- Action: Heart, Blood Vessels & Kidney
	- Elimination: Liver (Biliary) & Kidney


#### **Ion Channel Drugs**
- Aim: ↓ Lowers Ca<sup>2+</sup> Influx → ↓ Cardiac & Smooth Muscle Contractility
	- <abbr Title="Calcium Channel Blockers">CCB</abbr>
	- Potassium Channel Openers
- Ca<sup>2+</sup> Role in Muscle Contraction:

| Step | Event                                                            |
| ---- | ---------------------------------------------------------------- |
| 1    | Changes Tropomyosin conformation                                 |
| 2    | Myosin detach from Tropomyosin & binds to Actin temporarily (出軌) |
| 3    | Muscle Contraction                                               |

**Calcium Channel Blockers (CCB)**
- Suffix: -dipine (e.g. Nifedipine, Lercanidipine, Felodipine)

| Step | Event           | Description                                                                    |
| ---- | --------------- | ------------------------------------------------------------------------------ |
| 1    | AT1R Inhibition | Selective Blockage of <abbr Title="Angiotensin II Type 1 Receptor">AT1R</abbr> |
| 2    | ↓ AT1R Effect   | Vasodilation <br>↓ Aldosterone & Sympathetic Activity                          |
| 3    | ↓ Aldosterone   | ↓ Na<sup>+</sup> & Water Reabsorption                                          |
